Evoke Pharma (EVOK) Misses Q2 EPS by 62c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.62). Revenue for the quarter came in at $3.75 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• ZenaTech raises Plurilock Security stake to 12% with new share purchase
• Avis Budget Group reaches $650M settlement with Pentwater Capital